Trevor N Collingwood

Title: Innovations of Trevor N Collingwood

Introduction

Trevor N Collingwood is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation patterns in recombinant proteins. With a total of 2 patents, his work has implications for medical and pharmaceutical applications.

Latest Patents

Trevor's latest patents include a method of producing human-like glycosylation patterns using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase, and/or glycoprotein alpha-1,3-galactosyltransferase. This invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Additionally, he has developed methods for using these cells to produce recombinant proteins with human-like patterns of glycosylation.

Career Highlights

Trevor N Collingwood is currently associated with Sigma-Aldrich Co. LLC, where he continues to innovate and contribute to advancements in biotechnology. His expertise in glycosylation has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Nan Lin and Henry George, who collaborate with him on various projects within the company.

Conclusion

Trevor N Collingwood's work exemplifies the intersection of innovation and biotechnology, showcasing his commitment to advancing the field through his patents and collaborations. His contributions are paving the way for future developments in recombinant protein production.